FYVE, RhoGEF and PH Domain Containing 3 (FGD3) (Middle Region) Peptide
FGD3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all FGD3 products
- FGD3 (FYVE, RhoGEF and PH Domain Containing 3 (FGD3))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- STSPVEPVVT TEGSSGAAGL EPRKLSSKTR RDKEKQSCKS CGETFNSITK
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-FGD3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- FGD3 (FYVE, RhoGEF and PH Domain Containing 3 (FGD3))
- Synonyms
- ZFYVE5 Peptide, 5830461L01Rik Peptide, FYVE, RhoGEF and PH domain containing 3 Peptide, FGD3 Peptide, Fgd3 Peptide
- Background
-
FGD3 promotes the formation of filopodia. It may activate CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. FGD3 plays a role in regulating the actin cytoskeleton and cell shape.
Alias Symbols: FLJ00004, MGC117260, ZFYVE5
Protein Size: 634 - Molecular Weight
- 70 kDa
- Gene ID
- 89846
- NCBI Accession
- NM_033086, NP_149077
-
You are here:
